Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín Ortiz-Genga, Lorenzo Monserrat, Ricardo Salgado‐Aranda et al.|Journal of the American College of Cardiology|2016Cited by 472
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic CardiomyopathyMilind Y. Desai, Anjali Owens, Iacopo Olivotto et al.|Journal of the American College of Cardiology|2025Cited by 11